Individuals with end-stage renal disease (ESRD) or even those with earlier stages of chronic kidney disease have a markedly elevated risk of cardiovascular and cerebrovascular disease. In fact, 20% of individuals with ESRD die within a year of initiating maintenance dialysis, mainly of cardiovascular causes. Although earlier studies in ESRD patients focused on the risk of coronary and related cardiac diseases, more recent studies have indicated that risk of stroke and related cerebrovascular diseases is also greatly increased in this population. For example, Seliger et al. 1 reported that the risk of hospitalized stroke was 5 to 10 times greater among maintenance dialysis patients compared to the general population, after accounting for demographic differences; the risk was increased for both hemorrhagic and ischemic stroke. Kuo and colleagues 2 replicated these findings among their hemodialysis population in Taiwan. Sozio et al. 3 reported that among patients initiating maintenance dialysis, the risk of cerebrovascular events, comprising hospitalized and fatal stroke and carotid artery revascularization, was nearly 5% per year. One-half of ESRD patients on maintenance dialysis have evidence of prior infarct on brain imaging, a rate 5 times that of age-matched individuals from the general population. 4 Factors that may explain the high risk of cerebrovascular events in ESRD include a higher burden of traditional vascular risk factors (e.g., hypertension, diabetes, dyslipidemia), a process of accelerated atherosclerosis induced by uremia, 5 and potentially the acute reductions in cerebral blood flow during hemodialysis procedure. 6 Although the relative contribution of these factors in causing this marked elevation in stroke risk is uncertain, it is clear that outcomes after stroke in ESRD patients are very poor, with a 35% case fatality rate and only 56% of cases being discharged home or to acute rehabilitation. 3 Furthermore, the recognition of stroke cases is substantially delayed in this population of patients, with an average of 8.5 hours elapsing from the onset of symptoms and presentation to clinical care. 3 These findings suggest that there is a failure to recognize acute stroke symptoms by ESRD patients and potentially even by the health care providers.
In this issue of Neurology ® , Tamura et al. 7 report on the frequency and clinical importance of prior stroke symptoms in a population of ESRD patients on maintenance hemodialysis but no history of diagnosed stroke or transient ischemic attacks. Of the 126 participants in this study, 36.5% reported having 1 or more stroke symptoms in the past. Although the baseline characteristics of individuals with and without prior stroke symptoms in this study were not different, presence of prior stroke symptoms was associated with worse cognitive and functional performances. These findings remained significant even after adjustments for patient demographics, presence of diabetes, and cardiovascular diseases. In the multivariate analysis, presence of prior stroke symptoms was associated with almost 2.5-fold higher likelihood of cognitive impairment, as determined by scores on a multi-item neurocognitive battery, and almost 3.5-fold higher likelihood of self-reported functional impairment.
While the mean age of the participants in this study might have been slightly younger than the US ESRD population, the study sample is a good representation overall of the US ESRD population, with high prevalence of diabetes (40%-45%) and hypertension (Ͼ90%). Among the limitations of the study are its small sample size, the sole use of self-report to exclude patients with confirmed strokes or TIA, and the cross-sectional design of the study. Furthermore, the instrument used to identify prior stroke symptoms (the QVSFS) has relatively modest specificity in identifying patients with prior stroke, and information was not available on the timing of such symptoms with regards to onset of ESRD. However, despite these shortcomings, the findings of this study have the potential to influence clinical practice as well as future research in this field.
In light of the accumulating evidence regarding the problem of stroke and its under-recognition in ESRD-to which the study of Tamura and colleagues represents a significant contributiongreater efforts are clearly required to increase recognition of potential stroke symptoms among ESRD patients to enable timely intervention. It might be reasonable for health care providers to assess the presence of stroke symptoms and to have lower thresholds for further workup for those with these symptoms. ESRD patients on hemodialysis come into contact with health care providers several times a month, which provides a great opportunity for early detection of these symptoms, potentially reducing morbidity and mortality in this group of patients. As we have argued previously, 8 appropriate recognition of such events requires a high index of suspicion, regular surveillance, and, perhaps most importantly, a close collaboration between nephrologists and neurologists.
Future research should focus on the development of more specific instruments to screen for potential stroke symptoms in ESRD; as the authors note, the instrument utilized in the present study was designed to screen for stroke-free status rather than specifically to identify those with stroke symptoms. Ideally, any new instruments should be validated prospectively in maintenance dialysis patients to determine if they can reasonably distinguish symptoms related to ischemic brain events from other causes of focal symptoms that can occur in this patient population, such as arterial steal syndrome from arteriovenous dialysis fistulas.
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